Jullian G. Jones - 01 Dec 2021 Form 3 Insider Report for Monte Rosa Therapeutics, Inc. (GLUE)

Role
Chief Business Officer
Signature
/s/ Jullian G. Jones
Issuer symbol
GLUE
Transactions as of
01 Dec 2021
Net transactions value
$0
Form type
3
Filing time
02 Dec 2021, 17:12:36 UTC
Next filing
02 Mar 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding GLUE Stock Option Grant (Right to Buy) 01 Dec 2021 Common Stock 187,225 $2.19 Direct F1
holding GLUE Stock Option Grant (Right to Buy) 01 Dec 2021 Common Stock 64,369 $6.14 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of this option shall vest and become exercisable on August 31, 2021, with the remainder vesting in 36 substantially equal monthly installments thereafter.
F2 25% of this option shall vest and become exercisable on April 9, 2022, with the remainder vesting in 36 substantially equal monthly installments thereafter.

Remarks:

Exhibit 24 - Power of Attorney No securities are beneficially owned.